Milliman Healthcare Inflation Plus ETF
MHIP
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Bonds
- Address
- 71 S. Wacker Dr., Floor 31 Wilmington DE United States of America 60606
- IPO Date
- Apr 21, 2026
- CIK
- 0002096904
- Website
- millimanfunds.com
- Similar Companies
- Business
- Milliman Healthcare Inflation Plus ETF (MHIP) is an active exchange-traded fund managed by Milliman Financial Risk Management LLC (Milliman FRM) that seeks to deliver returns over time that exceed the U.S. healthcare cost inflation rate. The fund is designed to provide exposure to hedging tools and asset classes that Milliman believes correlate with U.S. healthcare cost inflation, using a diversified, actively managed approach across equities, fixed income, and alternatives to capture changes in healthcare costs for individuals enrolled in employer-provided plans. MHIP began trading on NYSE Arca in 2026 and is part of Milliman’s family of healthcare inflation ETFs, alongside MHIG, which seeks to generate returns generally equivalent to healthcare cost inflation over time. The fund employs a monthly rebalancing framework aligned to Milliman’s HTG (Health Trend Guidelines) benchmarks and maintains a higher risk asset tilt relative to MHIG to pursue potential outperformance against healthcare inflation over time. The expense structure includes a net expense ratio of 0.55%, with gross expense ratios around 0.56%–0.58% and an AFFE (acquired fund fees and expenses) provision that is waived through at least April 30, 2027, subject to fund terms. MHIP’s target exposure focuses on U.S. healthcare equities and related debt, including bonds issued by healthcare entities, with hedging components such as commodities, TIPS, and U.S. Treasuries to manage inflation sensitivity, and it employs a quantitative framework to integrate equity, fixed income, and inflation-hedging instruments. MHIP’s core objective centers on generating a return profile that tracks or exceeds U.S. healthcare cost inflation, thereby assisting investors in managing the financial impact of rising healthcare costs on employer-sponsored plan participants. MHIP targets institutional and retail investors seeking inflation-hedged exposure to the U.S. healthcare sector and its supply chain, including exposure to U.S.-listed healthcare stocks and ADRs, corporate bonds of healthcare issuers, and inflation-hedging assets within a single, liquid vehicle. The fund operates within a broader Milliman ETF suite focused on healthcare cost dynamics and employs Milliman’s quantitative modeling and research expertise to guide asset allocation and risk management decisions. MHIP’s issuer and strategic context situate Milliman FRM as the investment adviser, leveraging Milliman’s actuarial and risk-management capabilities to structure a product intended to address healthcare inflation risk for retirement savers and plan participants. MHIP’s geographic footprint is anchored in the United States with underlying holdings primarily comprising U.S. healthcare companies and related fixed-income instruments, while the fund’s strategy controls are calibrated to respond to U.S. HTG-based healthcare inflation signals. The latest changes include the launch of MHIP as part of a dual ETF rollout with MHIG in 2026, designed to offer two related but distinct inflation-linked approaches to the healthcare cost inflation challenge, with ongoing monthly rebalancing and an explicit alignment to Milliman’s HTG benchmarks; this represents a strategic expansion of Milliman’s ETF platform into active, inflation-focused healthcare exposure. MHIP is part of Milliman’s broader initiative to deliver sophisticated risk-management and investment solutions for healthcare inflation, leveraging Milliman FRM’s actuarial insight and proprietary quantitative modeling to optimize the balance between risk assets and hedging instruments in pursuit of long-run real returns for investors facing rising healthcare costs. MHIP’s operations are headquartered in the United States with Milliman FRM serving as investment adviser, reinforcing Milliman’s role as a global actuarial and risk-management firm expanding into asset-management products targeting healthcare inflation risk across developed markets. The fund is positioned for professional and institutional distribution through U.S. channels and is accessible to investors seeking a dedicated healthcare inflation hedging vehicle, with ongoing performance monitoring against healthcare cost inflation benchmarks and adherence to the fund’s monthly rebalancing discipline. MHIP’s products and services emphasize active asset management, structured for healthcare cost exposure rather than passive tracking, with supplementary optionalities and hedging strategies designed to cushion the impact of rising medical costs on beneficiary portfolios. MHIP’s evolution will likely include continued refinements to the quantitative model, potential expansion of underlying asset classes, and additional strategic partnerships within Milliman’s ecosystem to broaden access to healthcare inflation hedging capabilities.